Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men with Prostate Cancer (SYNERGY)October 16, 2012Genitourinary Cancer
Study of Cabozantinib (XL184) Versus Mitoxantrone plus Prednisone in Men with Previously Treated Symptomatic Castration-resistant Prostate Cancer (COMET-2)October 16, 2012Genitourinary Cancer
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 (COMET-1)October 16, 2012Genitourinary Cancer
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceOctober 16, 2012Genitourinary Cancer
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Patients with a Rising PSA after Surgery for Prostate CancerOctober 16, 2012Genitourinary Cancer
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized TrialOctober 16, 2012Genitourinary Cancer
Radiation Therapy With or Without Androgen-Deprivation Therapy in Patients with Prostate CancerOctober 16, 2012Genitourinary Cancer
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Patients with High-Risk Prostate CancerOctober 16, 2012Genitourinary Cancer
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Patients With High-Risk Localized Prostate CancerOctober 16, 2012Genitourinary Cancer
Safety and Efficacy Study of Enzalutamide versus Bicalutamide in Men With Prostate Cancer (STRIVE)October 16, 2012Genitourinary Cancer
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Patients with Advanced Urinary Tract CancerOctober 16, 2012Genitourinary Cancer
